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The prolonged presence of aerobic Gram-negative bacilli (AGNB) in the oropharynx is termed ‘carriage’. AGNB 
carriage rates are low in populations of healthy individuals. Previously, severity of underlying disease has been 
positively correlated with oropharyngeal AGNB carriage rate. Overgrowth of AGNB at the oropharynx poses a 
significant risk of endogenous infection in end-stage chronic obstructive pulmonary disease (COPD) patients. The 
aims of this study were to undertake an epidemiological survey of the oropharyngeal flora of COPD patients and to 
correlate oropharyngeal carriage of AGNB with severity of disease. 
Two oral rinses were obtained, within a 2-day interval, from 40 COPD patients comprising three disease severity 
groups: 1. mild, 2. moderate and 3. severe. Eighty oral rinses were quantitatively (1: 10 dilution series) cultured for 
AGNB and yeasts using broth enrichment. 
The mean AGNB carriage rate was 15%. AGNB carriage rates of 0, 7.7 and 29.4% were observed within the 
mild, moderate and severe disease groups, respectively. The mean yeast carriage rate was 33.3%. Yeast carriage 
rates of 33.3, 15.4 and 64.7% were observed within the mild, moderate and severe disease groups, respectively. 
Carriage of Staphylococcus aUYeU.s was 5%. Rates of oropharyngeal carriage of AGNB (l/23 vs. 5/17) and yeasts 
(5/23 vs. 1 l/17) were significantly higher within the severe disease group than in non-severe disease groups. 
Oropharyngeal carriage of AGNB in end-stage COPD patients (forced expiratory volume in 1 set, FEVr < 50% 
predicted) presents a potential source of Gram-negative endogenous pneumonia. This outcome may be promoted 
by intubation and some flora-suppressing antibiotic therapies. 
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Introduction 
Normal oropharyngeal flora consists of a variety of 
anaerobes (e.g. peptostreptococci, VeiUoneZZa spp.) at 
concentrations of approx. 1 x IO8 colony forming units 
(CFU) ml-’ of saliva. Aerobes are represented most 
prominently by viridans streptococci at approx. 1 x lo6 
CFU ml-’ of salvia. A variety of potentially pathogenic 
micro-organisms (PPM) are also found in the ‘normal’ 
oropharyngeal flora such as the ‘community micro-organ- 
isms’ Streptococcus pneumoniae, Haemophilus influenzae, 
Staphylococcus aureus and Candida spp. ‘Abnormal’ 
oropharyngeal flora are opportunistic aerobic Gram- 
negative bacilli (AGNB), also termed ‘hospital 
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micro-organisms’, e.g. Klebsiella spp., Enterobacter spp. 
and Pseudomonas spp. All AGNB are considered potential 
pathogens. Carriage of abnormal oropharyngeal flora 
appears uncommon in healthy individuals due to the low 
availability of AGNB-receptor sites within the healthy oral 
mucosae and the efficacy of innate host factors aimed at 
clearance of abnormal oropharyngeal flora (1). Underlying 
illness is thought to be the most important single factor 
associated with increased availability of AGNB-receptor 
sites within the oropharyngeal mucosae. The literature 
suggests that, within a particular subset of patients, 
prevalence of the AGNB carrier state reflects illness severity 
(24). Literature searches using the mesh words ‘chronic 
obstructive pulmonary disease (COPD)‘, ‘AGNB’ and 
‘oropharyn’ revealed three surveys of AGNB carriage 
within populations with COPD (5-7). AGNB carriage 
rates varied between 5 and 18%. However, illness severity 
was not accounted for in these studies. A prospective pilot 
study was undertaken in a population of 40 outpatients 
with COPD to evaluate carriage rates of AGNB according 
to illness severity. 
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Materials and Methods 
COPD OUTPATIENTS 
In total, 40 outpatients were enrolled in this study and 
fultllled the following criteria: 1. age older than 16 years; 2. 
complaints of shortness of breath, wheezing, dyspnoea on 
effort, cough and sputum production; 3. a clinical diagnosis 
of COPD made at least once in the past 10 years by a 
pulmonologist; 4. absence of obvious respiratory infection; 
and 5. absence of antimicrobial chemotherapy in the 4 
weeks preceding sampling. 
SEVERITY OF DISEASE 
Disease severity was assessed purely on the basis of 
spirometry. Outpatients were segregated according to the 
forced expiratory volume in 1 set (FEVi) as a percentage of 
predicted normal values. Subjects classed as suffering mild, 
moderate and severe disease had FEVi values of 170, 
69-50% and ~50% of predicted normal values, respec- 
tively (8). 
MANAGEMENT OF COPD 
Outpatients attending clinics and diagnosed as suffering 
COPD were normally prescribed a /I-adrenergic agonist 
and inhaled steroid. More severe cases may have been 
prescribed ipratropium bromide. Antibiotic prophylaxis 
and N-acetylcysteine were considered inappropriate. Anti- 
biotics were prescribed curatively for 1 week only in cases 
of infectious exacerbations of COPD (9). 
SAMPLING 
Oropharyngeal samples were obtained via an oral rinse and 
gargle technique. Patients were presented with 10 ml of 
sterile isotonic saline and told to rinse and gargle the 
solution vigorously for 10 set before expectorating the 
sample into a sterile receptacle. All samples were processed 
within 2 h of sampling. 
Sampling frequency was twice in 1 week on Tuesdays and 
Thursdays between 1000 and 1200 hours. Sampling times 
were maintained to avoid false positive results due to 
ingestion of contaminated foodstuffs. Clearance of even 
large numbers of AGNB from the oropharynx is reported 
to occur within 3 h in healthy individuals. 
CULTURE TECHNIQUES (10) 
One ml of oropharyngeal sample was diluted lo-fold in 
Nutrient Broth (Oxoid, Basingstoke, Hampshire, U.K.). 
Ten-fold dilution series were made in well-trays of 64 (8 x 8) 
cups of 1.5 ml volume (WHO trays; Redhill Surgical Co. 
Ltd, Glasgow, U.K.), containing 0.45 ml Nutrient Broth. 
To the first cup, a 0.05 ml aliquot of the diluted (1 x 10-I) 
sample was added, yielding a further ten-fold dilution 
(1 x lo-‘). Subsequent cups were inoculated with 0.05 ml 
aliquots from the previous cup to a dilution of 1 x lo-‘. 
All samples were incubated at 37” C for 18-24 h. 
Following incubation, the well-trays were scored for 
turbidity. The number of cups showing turbidity due to 
bacterial growth indicates the highest logis concentration of 
micro-organisms per ml of oropharyngeal sample. 
All dilutions displaying a degree of turbidity were 
subcultured onto MacConkey agar with crystal violet, 
Columbia blood agar and Sabouraud dextrose agar with 
lactic acid. All prepared media were obtained from Lab M, 
Bury, U.K. 
AGNB (e.g. Enterobacteriaceae, Pseudomonadaceae and 
Acinetobacter spp.), yeast, and streptococci and staphylo- 
cocci were evaluated on MacConkey agar, Sabouraud 
dextrose agar and Columbia blood agar, respectively. 
Morphologically distinct colonies were identified by 
colonial and cellular morphology. Staphylococci identified 
through colonial morphology were tested by the slide 
coagulase test (all coagulase-positive isolates were taken to 
be the Staphylococcus aureus. 
All suspected AGNB isolated from MacConkey agar 
were isolated in pure culture on Columbia blood agar 
and identified by means of the API 20 E analytical test 
(bioMerieux sa, Marcy-l’Etoile, France). Identification of 
microorganisms was based on the same biochemical profile. 
DEFINITIONS (11) 
Carriage 
Carriage, or a carrier state, exists when the same bacterial 
strain is isolated from at least two consecutive surveillance 
samples. 
Acquisition 
The patient is considered to have acquired a micro- 
organism if only one of two surveillance samples is positive 
for a micro-organism that differs from the previous and 
following isolates. Acquisition refers to the transient 
presence of a micro-organism. 
Indigenous Flora 
Micro-organisms carried by healthy people at high con- 
centrations (2 1 x lo6 CFU ml-‘), e.g. viridans strepto- 
cocci. 
Community PPM 
Micro-organisms carried at the oropharynx by varying 
percentages of the healthy population, e.g. Staphylococcus 
aureus and Candida albicans. 
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TABLE 1. Age and sex distribution among 40 COPD 
outpatients 
Age COPD outpatients 
(years) (n) 
30-39 3 
40-49 3 
50-59 11 
60-69 12 
7c79 10 
80-89 1 
Men 22 
Women 18 
Hospital PPM 
Includes the aerobic Gram-negative bacilli (AGNB), also 
termed ‘opportunistic’ or ‘abnormal’ micro-organisms. 
STATISTICAL ANALYSIS 
Statistical analysis was performed using Fisher’s exact test. 
Due to the small numbers involved in some subject groups 
Yates’ correction factor was utilized. Ninety-five percent 
confidence intervals (95% CI) were calculated using 
Woolf s approximation. 
Results 
The group of 40 COPD outpatients was composed of 
approximately equal numbers of men and women. The 
modal age group was 60-69 years (Table 1). 
A total of 80 oral rinses were obtained (two per patient). 
All patients carried indigenous flora, represented by 
viridans streptococci, at concentrations of 21 x lo4 CFU 
ml-‘. The total mean AGNB carriage rate within the 
outpatient population was 15.0% (six individuals). AGNB 
carriage rates within the mild, moderate and severe disease 
severity groups were 0, 7.7 and 29.4%, respectively 
(Table 2). The difference in AGNB carriage rate between 
non-severe (one in 23, or 4.3%) (including mild and 
moderate sub-groups) and severe (five in 17, or 29.4%) 
disease subpopulations was statistically significant (95% CI 
0.9567-87.834). Three patients carried oropharyngeal 
AGNB at concentrations of > 1 x lo3 CFU ml-‘, whilst 
two yielded AGNB at 1 x lo4 CFU ml-’ and one patient 
carried one AGNB at the oropharynx at 2 1 x lo6 CFU 
ml-’ (Table 3). Within 3 days of sampling, this patient 
with oropharyngeal overgrowth of Klebsiella oxytoca 
developed pneumonia due to the same organism. Total 
mean yeast carriage rate within the outpatient population 
was 33.3% (16 individuals). Yeast carriage rates within the 
mild, moderate and severe disease severity groups were 
33.3, 15.4 and 64.7%, respectively (Table 2). Oropharyn- 
geal carriage of yeasts was significantly higher within the 
severe (1 l/17) disease group compared with non-severe [5/ 
231 groups (95% CI 1.621-26.881). No patients carried 
yeasts at concentrations higher than 1 x lo4 CFU ml-’ 
(Table 3). 
The total mean rates of acquisition of AGNB and yeasts 
within the outpatient populations were 45% (18 indivi- 
duals) and 15% (six individuals), respectively. The modal 
concentration of acquired AGNB and yeasts was 1 x 10’ 
CFU ml- ‘. However, six patients acquired oropharyngeal 
AGNB at concentrations > 1 x lo3 CFU ml-‘. 
Escherichia coli was the AGNB most frequently recov- 
ered from the oropharynx of patients in cases of carriage 
and acquisition (Table 4). The Staphylococcus aureus 
carriage and acquisition rates were 5 and 17.5%, respec- 
tively. Staphylococcus aureus was not recovered from any 
patient at concentrations above 1 x lo4 CFU ml-‘. 
Discussion 
The aim of this study within a population of ambulatory 
COPD outpatients was to execute an epidemiogical pilot 
study to evaluate rates of carriage and acquisition of 
aerobic Gram-negative bacilli (AGNB) in the oropharynx 
TABLE 2. Incidence of carriage of AGNB and yeasts in relation to severity of COPD 
Disease severity* .+ AGNB carriers 
n (%) 
Yeast carriers 
n (“x3) 
Mild 
(FEVi 2 70%) 
Moderate 
(FEVi 69-50%) 
Severe 
(FEV, < 50%) 
10 0 (0.0) 3 (33.3) 
13 1 (7.7) 2 (15.4) 
17 5 (29.4) 11 (64.7) 
Total 40 6 (150) 16 (40.0) 
*Disease severity assessed by spirometry and expressed as a percentage of expected forced expiratory volume in 1 set (FEVi). 
+Number of outpatients within severity group. 
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TABLE 3. Number of patients shown to carry and acquire AGNB and yeasts at the given concentrations. 
Logie concentrations (CFU ml-‘) of micro-organisms recovered from the oropharynx 
1 2 3 
AGNB 
Carriage 1 1 1 2 - 1 
Acquisition 8 4 4 1 1 - 
Yeasts 
Carriage 3 6 1 6 - - 
Acquisition 5 - 1 - - - 
using a sensitive and quantitative multiple survey method. 
Carriage and acquisition rates for AGNB in the whole 
study group were 15 and 45%, respectively. 
The main fmding of this pilot study was that illness 
severity correlates positively with oropharyngeal carriage 
rates of both AGNB and yeasts. The group of COPD 
patients scoring 2 50% of predicted FEVt (23 individuals) 
yielded only one carrier of oropharyngeal AGNB (4.3%). 
The patients scoring ~50% of predicted FEVi (17 
individuals) yielded five carriers of oropharyngeal AGNB 
(29.4%). Although the population studied here is small, the 
results prove statistically significant and highlight the need 
for similar studies performed within larger populations. 
The precise physiological mechanisms of abnormal 
Gram-negative orpharyngeal carriage are as yet unknown. 
However, healthy individuals are capable of eliminating 
larger numbers of AGNB from the oropharynx within 3 h of 
inoculation (12). Such rapid clearance is possible due to the 
efficacy of seven innate host factors (12-18) and, also, the 
apparent absence of mucosal receptors for AGNB. It is 
hypothesized that these receptor molecules are constitutively 
expressed, but are covered by a protective layer of 
fibronectin in the healthy mucosae. Significantly increased 
levels of salivary elastase have been shown to precede Gram- 
negative colonization of the oropharynx in post-operative 
TABLE 4. Incidence of acquisition and carriage of different 
AGNB throughout the COPD outpatient group 
Micro-organism Acquisition* 
n (Oh) 
Carriage* 
n (%) 
Escherichia coli 8 (20.0) 3 (7.5) 
Enterobacter spp. 4 (10.0) 0 (0.0) 
Serratia spp. 2 (5.0) 1 (2.5) 
Klebsiella spp. 1 (2.5) 1 (2.5) 
Proteus spp. 2 (5.0) 1 (2.5) 
Citrobacter spp. 0 (0.0) 0 (0.0) 
Other 1 (2.5) 0 (0.0) 
*Number of outpatients 
patients (19). It is probable that in individuals suffering both 
chronic and acute underlying illness, circulating populations 
of activated macrophages release elastase into mucosal 
secretions thereby denuding the protective fibronectin layer. 
It is thought that this hypothetical mechanism is a 
deleterious consequence of the inflammatory response 
encountered during and after illness. 
It is possible that the yeast carriage rates reported in this 
paper are also a consequence of the aforementioned 
mechanisms and, therefore, correlate with disease severity. 
However, several other factors may be at work within the 
patient group. Many COPD patients undergo prolonged 
steroidal chemotherapy, which has been implicated in oral 
candidiasis (8). Both advanced age and denture wearing 
have previously been correlated with increased prevalence 
of yeasts within the oropharynx (20,21). Considering the 
modal age group of the patients (60-69 years), and the fact 
that edentate individuals were not discriminated, it is not 
possible to correlate accurately severity of disease with 
yeast carriage rate. 
Aspiration of contaminated oropharyngeal secretions is 
the predominant mechanism of nosocomial lower airway 
infection. Streptococcus pneumoniae, Haemophilus influen- 
zae and Moraxella catarrhalis are the main causative 
organisms involved in infectious exacerbations of COPD 
in patients not undergoing antimicrobial chemotherapy 
(22-24). Even during the simultaneous carriage of the 
aforementioned respiratory pathogens and AGNB, Strep- 
tococcus pneumoniae, H. influenzae and M. catarrhalis pose 
a far greater risk of lower airway infection than AGNB due 
to their higher intrinsic virulence. This is in agreement with 
the majority of studies on community-acquired pneumonia 
in COPD patients (25-27). 
This pilot study shows a significantly ‘increased AGNB 
carriage in the severe COPD group scoring ~50% 
predicted FEVi. Primary endogenous pneumonia due to 
AGNB within the oropharyngeal flora of the COPD 
patients on admission varied between 5 and 17% in the 
community-acquired pneumonia studies within COPD 
patient populations (5-7). 
Many COPD patients will eventually require mechanical 
ventilation (28). Practically all ventilated COPD patients 
receive parenteral antimicrobials. Our findings suggest that 
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end-stage COPD patients require systemic antibiotics 
effective for both ‘community’ and ‘hospital’ micro-organ- 
isms. The commonly used antimicrobials are all capable of 
eliminating the three main respiratory pathogens from both 
the oropharynx and lower airways (29). Most antimicro- 
bials used for this purpose do not attain sufficiently high 
working concentrations in saliva for bactericidal action 
against many AGNB (30). Underlying disease, intubation 
and often suppression of normal indigenous oropharyngeal 
flora are known to promote overgrowth of AGNB (1). 
Oropharyngeal overgrowth is an independent risk factor 
for colonization and infection of the lower airways (31). It 
is likely that severity of COPD and associated immuno- 
suppression determines progression to superinfection and 
secondary endogenous AGNB pneumonia (32). 
Acknowledgements 
We wish to thank all patients involved in this study for their 
time and co-operation. 
References 
1. van Saene HKF, Stoutenbeek CP, Torres A. The 
abnormal oropharyngeal carrier state: symptom or 
disease? Respir Med 1992; 86: 183-186. 
2. Johanson WG, Pierce AK, Sanford JP. Changing 
pharyngeal flora of hospitalised patients. N Engl J 
Med 1969; 281: 1137-l 140. 
3. Garrouste-Orgeas M, Marie 0, Rouveau M, et al. 
Secondary carriage with Acinetobacter baumannii and 
Klebsiella pneumoniae in an adult ICU population: 
relationship with nosocomial infections and mortality. 
J Hosp Infect 1996; 34: 279-289. 
4. Lortholary 0, Fagon JY, Buu Hoi A, et al. Nosocomial 
acquisition of multi-resistant Acinetobacter baumannii: 
risk factors and prognosis. Clin Infect Dis 1995; 20: 
790-796. 
5. Lees AW, McNaught W. Bacteriology of lower- 
respiratory-tract secretions, sputum, and upper-respira- 
tory-tract secretions in “normals” and chronic bronchi- 
tics. Luncet 1959; ii: 1112-1115. 
6. Butt HL, Clancy RL, Cripps AW et al. Bacterial 
colonisation of the respiratory tract in chronic bron- 
chitis. Aust NZ J Med 1990; 20: 35-38. 
7. Sachs APE, van der Waaij D, Groenier KH et al. 
Oropharyngeal flora in asthma and in chronic ob- 
structive pulmonary disease. Am Rev Respir Dis 1993; 
148: 1302-1307. 
8. Siafakas NM, Vermeire P, Pride NB, et al. Optimal 
assessment 62 management of chronic obstructive 
pulmonary disease (COPD). Eur Respir J 1995; 8: 
1398-1420. 
9. Madison JM, Irwin RS. Chronic obstructive pulmon- 
ary disease. Lancet 1998; 352: 467-473. 
10. Mobbs KJ, van Saene HKF, Sunderland D, et al. 
Oropharyngeal Gram-negative bacillary cariage: a 
survey of 120 healthy individuals. Chest 1999; 115: 
157&1576. 
11. van Saene HKF, Silvestri L, Baines P. Definitions. In 
van Saene HKF, Silvestri L, de la Cal MA, eds. 
Infection Control in the Intensive Care Unit. Milan: 
lSt edn. Springer-verlag, 1998: l-8. 
12. Laforce FM, Hopkins J, Trow R et al. Human oral 
defences against Gram-negative rods. Am Rev Respir 
Dis 1976; 114: 929-935. 
13. Macfarlane TW, Mason DK. Local environmental 
factors in host resistance to the commensal microflora 
of the mouth. In: MacPhee T, ed. Host Resistance to 
Commensal Bacteria. London: Churchill Livingstone, 
1972: 6475. 
14. Ayars GH, Altam LC, Fretwell MD. Effect of decreased 
salivation and pH on the adherence of Klebsiella species 
to human buccal epithelial cells. Infect Zmmun 1982; 38: 
179-182. 
15. Bloomfield AL. The fate of bacteria introduced into the 
upper air passages. II. Bacillus coli and Staphylococcus 
albus. Bull Johns Hopkins Hosp 1920; 31: 1419. 
16. Dreizen S, Gilley EJ, Spies TD. A comparison of the 
prevailing cell types in saliva of persons with and 
without periodontal disease. Oral Surg 1956; 9: 278-283. 
17. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Absorption 
of immunoglobin A onto oral bacteria in vivo. J 
Bacterial 1968; 96: 242-249. 
18. Sprunt K, Leidy G. The use of bacterial interference 
to prevent infection. Can J Microbial 1988; 34: 
332-338. 
19. Dal Nogare AR, Toews GB, Pierce AK. Increased 
salivary elastase precedes Gram-negative bacillary 
colonisation in postoperative patients. Am Rev Respir 
Dis 1987; 135: 671-675. 
20. Kleinegger CL, Lockhart SR, Vargas K et al. 
Frequency, intensity, species and strains of oral 
Candida vary as a function of host age. J Clin Microb 
1996; 34: 22462254. 
21. Wilkieson CP, Samaranayake LP, MacFarlane TW 
et al. Oral candidosis in the elderly in long term 
hospital care. J Oral Path01 Med 1991; 20: 13-16. 
22. Leeper KV. Severe community-acquired pneumonia. 
Semin Respir Infect 1996; 11: 96 -108. 
23. Fagon J-Y, Chastre J. Severe exacerbations of COPD 
patients: the role of pulmonary infections. Semin Respir 
Znfect 1996; 11: 109-118. 
24. Potgieter PD, Hammond JMJ. Etiology and diagnosis 
of pneumonia requiring ICU admission. Chest 1992; 
101: 199-203. 
25. Gump DW, Phillips CA, Forsyth BR, et al. Role of 
infection in chronic bronchitis. Am Rev Respir Dis 
1976; 113: 465474. 
26. Leroy 0, Santre C, Beuscart C, et al. A five year 
study of severe community acquired pneumonia with 
emphasis on prognosis in patients admitted to an 
intensive care unit. Zntens Care Med 1995; 21: 24-31. 
27. Torres A, Dorca J, Zalacain R, et al. Community 
acquired pneumonia in chronic obstructive pulmonary 
disease. Am J Respir Crit Care Med 1996; 154: 
1456-1461. 
~OPIURY~EAL GRAM-NEGATIVE BACILLJ IN COPD 545 
28. Moran JL, Green JV, Homan SD et al. Acute 
exacerbations of chronic obstructive pulmonary disease 
and mechanical ventilation; a reevaluation. Crit Care 
Med 1998; 26: 71-78. 
29. Saint S, Bent S, Vittinghoff E et al. Antibiotics in 
chronic obstructive pulmonary disease exacerbations. 
JAMA 1995; 273: 957-960. 
30. Fink MP, Snydman DR, Niederman MS, et al. 
Treatment of severe pneumonia in hospitalised 
patients: results of multicenter, randomized, double 
blind trial comparing intravenous ciprofloxacin with 
imipenem-cilastatin. Antimicrob Agents Chemother 
1994; 38: 547-557. 
31. van Uffelen R, van Saene HKF, Fidler V et al. 
Oropharyngeal flora as a source of bacteria colonizing 
the lower airways in patients on artificial ventilation. 
Zntens Care Med 1984; 10: 233-237. 
32. Eller J, Ede A, Schaberg T, et al. Infective exacer- 
bation of chronic bronchitis. Chest 1998; 113: 
1542-1548. 
